TNFR1 signaling converging on FGF14 controls neuronal hyperactivity and sickness behavior in experimental cerebral malaria.

"Declarations Ethics approval and consent to participateAll experiments described in this study were carried out in accordance with the National Institute of Health (NIH) guidelines for the Care and Use of Laboratory Animals and were approved by the University of Texas Medical Brach Institutional Animal Care and Use Committee. Consent for publicationNot applicable. Competing interestsThe authors have no competing interests. Competing interests The authors have no competing interests."

"Funding This work was supported by the National Institute of Health (NIH) Grant R01 MH095995 (F.L.), R01MH111107 (F.L., J.Z.), NIH Grant R01NS106597 (R.S., G.V.), UTMB Institute Human Infection and Immunity Pilot (R.S., F.L.), John Sealy Memorial Endowment Fund (F.L.), the John D. Stobo, M.D. Distinguished Chair Endowment (J.Z.), the Edith and Robert Zinn Chair Endowment in Drug Discovery (J.Z.), Cancer Prevention and Research Institute of Texas (CPRIT) Grant RP190617 (E.H.S), the Houston Area Molecular Biophysics Program Grant No. T32 GM008280 (N.M.D), and Training Program funded by The National Institute of Aging (NIH Grant # T32AG067952-01; T.J.B.)."